148
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Cost-effectiveness of sensor-augmented insulin pump therapy vs continuous subcutaneous insulin infusion in patients with type 1 diabetes in the Netherlands

, , , , &
Pages 73-82 | Published online: 14 Jan 2019

References

  • Volksgezondheidenzorg.info [homepage on the Internet]Prevalence of diabetes by age and sex Available from: https://www.volksgezond-heidenzorg.info/onderwerp/diabetes-mellitus/cijfers-context/huidige-situatie#node-aantal-nieuwe-gevallen-van-diabetes-huisartsenpraktijkAccessed May 13, 2017
  • Volksgezondheidenzorg.info [homepage on the Internet]Cost of care for diabetes mellitus Available from: https://www.volksgezondheidenzorg.info/onderwerp/diabetes-mellitus/kosten/kosten#node-kosten-van-zorg-voor-diabetes-mellitus-naar-leeftijd-en-geslachtAccessed May 13, 2017
  • Fazeli FarsaniSSouvereinPCvan der VorstMMKnibbeCAde BoerAMantel-TeeuwisseAKChronic comorbidities in children with type 1 diabetes: a population-based cohort studyArch Dis Child2015100876376825877155
  • SpaansEAJMGusdorfLMAGroenierKHThe incidence of type 1 diabetes is still increasing in the Netherlands, but has stabilised in children under five (Young DUDEs-1)Acta Paediatrica2015104662662925640447
  • HicksDWhy is the UK lagging behind in the pump usage stakes?Journal of Diabetes Nursing200812105108
  • McknightJAWildSHLambMJGlycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparisonDiabet Med20153281036105025510978
  • HermanidesJNørgaardKBruttomessoDSensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trialDiabet Med201128101158116721294770
  • ŠoupalJPetruželkováLFlekačMComparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR StudyDiabetes Technol Ther201618953253827482825
  • HussainTAkleMNagelkerkeNDeebAComparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapySAGE Open Med201751205031211769493
  • HommelEOlsenBBattelinoTImpact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH studyActa Diabetol201451584585125037251
  • WeissRGargSKBodeBWHypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home StudyDiabetes Technol Ther201517854254726237308
  • GargSBrazgRLBaileyTSReduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE studyDiabetes Technol Ther201214320520922316089
  • BergenstalRMKlonoffDCGargSKThreshold-based insulin-pump interruption for reduction of hypoglycemiaN Engl J Med2013369322423223789889
  • PalmerAJRozeSValentineWJThe CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-makingCurr Med Res Opin2004201S5S26
  • PalmerAJRozeSValentineWJValidation of the CORE Diabetes Model against epidemiological and clinical studiesCurr Med Res Opin2004201S27S4015324514
  • McewanPFoosVPalmerJLLamotteMLloydAGrantDValidation of the IMS CORE Diabetes ModelValue Health201417671472425236995
  • PickupJCFreemanSCSuttonAJGlycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient dataBMJ2011343d380521737469
  • NathanDMClearyPABacklundJYIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesN Engl J Med2005353252643265316371630
  • LyTTNicholasJARetterathALimEMDavisEAJonesTWEffect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trialJAMA2013310121240124724065010
  • LynchPAttvallSPerssonSBarsoeCGerdthamURoutine use of personal continuous glucose monitoring system with insulin pump in Sweden [abstract 1052]Diabetologia201255Suppl 1S432
  • de VriesFMDenigPVisserSTHakEPostmaMJCost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the NetherlandsValue Health201417222323024636380
  • EeftingFNathoeHvan DijkDRandomized comparison between stenting and off-pump bypass surgery in patients referred for angioplastyCirculation2003108232870287614656913
  • Nederlands Huisarten Genootschap [homepage on the Internet] Available from: https://www.nhg.orgAccessed May 20, 2017
  • Medicijnkosten.nl [homepage on the Internet] Available from: https://www.medicijnkosten.nl/Accessed May 20, 2017
  • Nederlandse Zorgautoriteit [homepage on the Internet] Available from: https://www.nza.nl/regelgeving/tarieven/Accessed May 20, 2017
  • AdarkwahCCGandjourAAkkermanMEversSMCost-effectiveness of angiotensin-converting enzyme inhibitors for the prevention of diabetic nephropathy in The Netherlands – a Markov modelPLoS One2011610e2613922022539
  • Cz.nl Available from: http://www.cz.nl/~/media/actueel/voorwaarden/bijlagen-bij-basisverzekeringen/hulpmiddelen%20reglement.pdfAccessed March 11, 2014
  • RedekopWKStolkEAKokELovasKKaloZBusschbachJJDiabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatmentsDiabetes Metab200430654955615671925
  • SørensenJPlougUJThe cost of diabetes-related complications: registry-based analysis of days absent from WorkEconomics Research International20132013118
  • NørgaardKScaramuzzaABratinaNSensor-augmented pump therapy in real-life: patients reported outcomes results of the INTERPRET observational study Abstract 1058EASD Berlin 2012
  • NørgaardKScaramuzzaABratinaNRoutine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET studyDiabetes Technol Ther201315427328023438304
  • CurrieCJMorganCLPooleCDSharplinPLammertMMcewanPMultivariate models of health-related utility and the fear of hypoglycaemia in people with diabetesCurr Med Res Opin20062281523153416870077
  • McBrideMEgglestonASJonesTLyTHealth-Related Quality of Life in Patients with Type 1 Diabetes and Impaired Hypoglycaemia Awareness: The Role of Sensor-Augmented Insulin Pump Therapy with Automated Insulin SuspensionValue in Health2013167A448
  • College voor zorgverzekeringeGuidelines for pharmacoeconomic research, updated version College voor zorgverzekeringen2006
  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study GroupBeckRWLawrenceJMQuality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trialDiabetes Care201033102175217720696865
  • RozeSSmith-PalmerJValentineWJLong-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspectiveJ Med Econ201619323624226510389
  • RozeSde PortuSSmith-PalmerJDelbaereAValentineWRidderstråleMCost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in DenmarkDiabetes Res Clin Pract201712861428432898
  • RozeSSmith-PalmerJValentineWCost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in FranceDiabetes Technol Ther2016182758426646072
  • JendleJSmith-PalmerJDelbaereACost-Effectiveness Analysis of Sensor-Augmented Insulin Pump Therapy with Automated Insulin Suspension Versus Standard Insulin Pump Therapy in Patients with Type 1 Diabetes in SwedenDiabetes Ther2017851015103028871565
  • Diabeter: Our results, average HbA1c levels, international comparison data Available from: https://diabeter.nl/en/our-care/our-results/#international_comparisonAccessed May 20, 2017
  • NefsGBevelanderSHendrieckxCFear of hypoglycaemia in adults with Type 1 diabetes: results from Diabetes MILES – The NetherlandsDiabet Med201532101289129625764474
  • EmralRPathanFCortésCAYSelf-reported hypoglycemia in insulin-treated patients with diabetes: results from an international survey on 7289 patients from nine countriesDiabetes Res Clin Pract2017134172828951336
  • YeohEChoudharyPNwokoloMAyisSAmielSAInterventions That Restore Awareness of Hypoglycemia in Adults with Type 1 Diabetes: A Systematic Review and Meta-analysisDiabetes Care20153881592160926207053
  • Pedersen-BjergaardUPrammingSHellerSRSevere hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selectionDiabetes Metab Res Rev200420647948615386817
  • RooijackersHMWiegersECTackCJvan der GraafMde GalanBEBrain glucose metabolism during hypoglycemia in type 1 diabetes: insights from functional and metabolic neuroimaging studiesCell Mol Life Sci201673470572226521082
  • BrodMChristensenTThomsenTLBushnellDMThe impact of non-severe hypoglycemic events on work productivity and diabetes managementValue Health201114566567121839404
  • BattelinoTCongetIOlsenBThe use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialDiabetologia201255123155316222965294
  • López-BastidaJLópez-SigueroJPOliva-MorenoJSocial economic costs of type 1 diabetes mellitus in pediatric patients in Spain: CHRYSTAL observational studyDiabetes Res Clin Pract2017127596928319803